Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates
Date:5/7/2012
acted as the exclusive advisor to Coherus BioSciences in this licensing partnership with Daiichi Sankyo.
About Coherus BioSciences
Coherus BioSciences is an emerging biopharmaceutical company headquartered in the San Francisco Bay Area with an entirely new model for developing safe, high-quality biosimilar therapeutics. Founded in 2010, Coherus already has formed global partnerships with top tier pharma and filled the pipeline with five product candidates focused on treating oncology and inflammatory diseases. Led by a group of early biotech pioneers, Coherus has reinvented the entire business of developing biologic medicines, from concept to commercialization, so that more patients around the world can have greater access to quality therapeutics. For additional information, please visit www.coherus.com.
About Daiichi SankyoThe Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model," which will respond to market and customer diversity and optimize growth opportunities across the value chain. For more information, please visit www.daiichisankyo.com.
Contact: Maureen Lopez
Coherus BioSciences
Phone Number 1-800-794-5434
Media contact for Daiichi Sankyo Co. Ltd.: +81-3-6225-1126
'/>"/>
| SOURCE Coherus BioSciences Copyright©2010 PR Newswire. All rights reserved |
Related biology technology :
1. YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB
2. Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs
3. DAIICHI SANKYO EUROPE GmbH Selects DATATRAK eClinical™ for Pan-European Systolic Hypertension Study
4. Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom
5. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
6. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
7. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
8. Milestone Biosciences, LLC Further Strengthens Executive Management Team
9. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
10. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
11. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
Post Your Comments:
(Date:5/23/2013)... SAN MARINO, Calif. , May 23, 2013 ... announces today a strategic alliance with DAK Renewable ... increase the corn oil yield. VG Energy is ... Inc. (OTC Pink: VGLS). VG Energy,s ... pathways to increase the oil yield in plants, ...
(Date:5/23/2013)... BioTrends Research Group, one of the ... biopharmaceutical issues, finds that, unaided, one in five ... that in the past six months, they have ... anticipation of the next generation of HCV treatments—notably ... 6 percent reported that they had begun warehousing ...
(Date:5/23/2013)... BETHESDA, Md. , May 23, 2013 ... a biotechnology company developing DCVax ® personalized immune ... will use its exhibit at this year,s American Society ... to highlight its leadership role in immune ... The ASCO annual meeting is the pre-eminent conference ...
(Date:5/23/2013)... Verenium Corporation (Nasdaq: VRNM ), a ... commercialization of high-performance enzymes, today announced that ... at two upcoming conferences. (Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO ... Second Annual Marcum LLP Microcap Conference on Thursday, May ... York City. The presentation is scheduled to begin at ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3[0] VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials[0] The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments[0] NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer[0] Verenium To Present At Two Upcoming Conferences
... two worlds quantum physics and nano physics, and ... method for laser cooling semiconductor membranes. Semiconductors are vital ... and the efficient cooling of components is important for ... method works quite paradoxically by heating the material! Using ...
... , BUFFALO, N.Y. -- By tweaking the smallest of ... hoping to dramatically increase the amount of sunlight that ... the UB researchers have shown that embedding charged quantum ... enabling the cells to harvest infrared light, and by ...
... ST. LOUIS, Jan. 20, 2012 On Tuesday, January ... will vote on a shareholder proposal to create a ... with its chemical products and genetically modified organisms (GMOs). ... strongest signals to date that the biotech food conglomerate ...
Cached Biology Technology:Cooling semiconductor by laser light 2Cooling semiconductor by laser light 3In solar cells, tweaking the tiniest of parts yields big jump in efficiency 2Monsanto Attempts to Lockout Socially Responsible Shareholder at Annual Meeting 2(Date:5/22/2013)... Screening Trial (NLST) investigators also conclude that the ... low-dose computed tomography (LDCT) versus chest X-ray (CXR) ... is achievable at experienced screening centers in the ... to share with their patients about the benefits ... today,s publication in the New England Journal ...
(Date:5/22/2013)... major new effort to educate the public and decision ... clean water that looms ahead in the 21st century. ... current edition of Chemical & Engineering News , ... the world,s largest scientific society. , Bassam Z. Shakhashiri, ... Ph.D., explain that shortages of reliable supplies of fresh ...
(Date:5/22/2013)... potential environmental and human health effects from disposal ... has led scientists to recommend stronger government policies ... (Li-ion) battery materials. That,s the conclusion of a ... Science & Technology . , Oladele A. Ogunseitan ... become mainstays for powering everything from smart phones ...
Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3... researchers led by Kurt Kroenke, M.D., of the Indiana University ... nearly 20 percent of patients seen by primary care physicians ... effectiveness of a new screening tool which can alert busy ... anxiety disorders. The study is published in the March ...
... may help people regain strength and normal use of ... University of California, Irvine study. , Stroke ... grasp and release objects after therapy sessions using the ... least moderate residual weakness and reduced function of the ...
... ?a form of cancer associated with asbestos exposure ?have a ... cancer drugs, a large multicenter study finds. , Mesothelioma, a ... lining of the lungs, heart and abdomen, is associated with ... In the study, patients receiving pemetrexed and cisplatin ?along with ...
Cached Biology News:Anxiety disorders surprisingly common yet often untreated 2Robotic therapy helps restore hand use after stroke 2Robotic therapy helps restore hand use after stroke 3Chemo combination improves survival in asbestos-related cancer 2Chemo combination improves survival in asbestos-related cancer 3Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Anti-Potassium Channel Kv2.2 Immunogen: Synthetic peptide from rat Kv2.2. Available Date: 38376...
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface....
Biology Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |